Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
Clinical trial NCT02281409 · COMPLETED
Trial details
- NCT number
- NCT02281409
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2020-02-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.